Publications by authors named "M Boros"

Objective: To study the sex and hormonal effects on cortico-striatal engagement during drug cue-reactivity and its regulation focusing on drug reappraisal.

Methods: Forty-nine men (age=41.96±9.

View Article and Find Full Text PDF

Background: Wound healing is a complicated process that can be heavily influenced by patient comorbidities, in some cases leading to a chronic non-healing wound. Evidence presented in the medical literature supporting the clinical use of autologous platelet-rich plasma (PRP) in treatment of such wounds is becoming increasingly compelling. Mechanisms involved include complex interactions between the patient's thrombocytes, cytokines, and growth factors.

View Article and Find Full Text PDF
Article Synopsis
  • Malignant rhabdoid tumors mainly affect young children and are linked to genetic changes in the SMARCB1 gene; about 30% of patients have one altered SMARCB1 allele, leading to poorer outcomes.
  • A study of 29 patients with sporadic rhabdoid tumors investigated the frequency and impact of constitutional mosaicism (having mutated genes in some but not all cells) using advanced DNA sequencing techniques.
  • The research found constitutional mosaicism in 21% of patients, suggesting it is common in these tumors; however, there were no significant differences in clinical outcomes between patients with and without mosaicism, indicating more research is necessary.
View Article and Find Full Text PDF

Background: The increasing incidence of colorectal cancer is one of the most frequently addressed medical topics worldwide. It represents the third most commonly diagnosed cancer in both men and women globally, with significant implications for public health. Mortality for this type of malignancy remains high, second only to lung cancer.

View Article and Find Full Text PDF

Non-small-cell lung cancer (NSCLC) is the leading cause of cancer-related death worldwide, with ~40-50% of patients diagnosed with non-metastatic disease (stages IA-IIIC). The treatment landscape is evolving rapidly as immunotherapies and targeted therapy are introduced in the non-metastatic setting, creating a need to assess patient outcomes prior to their introduction. This real-world study using Swedish National Lung Cancer Registry data examined outcomes (overall survival (OS) and time to next treatment or death (TTNTD)) and treatment patterns for adults diagnosed with non-metastatic NSCLC.

View Article and Find Full Text PDF